Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1440 of 5804
-
Can these drugs ease long COVID? new trial aims to find out
Symptom relief CompletedThe researchers propose to develop a Canada-wide, adaptive randomized clinical platform trial to assess the effectiveness of various interventions in patients with lingering symptoms of COVID-19 ("Long COVID"). Participants will be randomized initially to 1 of 3 arms, including p…
Phase: PHASE2, PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Could a simple scan replace biopsies for key cancer marker?
Diagnosis Recruiting nowTo evaluate the potential usefulness of 68Ga-NK224 positron emission tomography/computed tomography (PET/CT) for the evaluation of PD-L1 expression in primary and/or metastatic tumors, compared with histopathological results.
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Psychedelic nasal spray shows promise for alcohol addiction in small trial
Disease control CompletedAn open-label, Phase 2a study to evaluate the safety, tolerability, and pharmacodynamic effects of a single intranasal dose of BPL-003 combined with relapse prevention psychological support, to explore the potential effects on alcohol use and related symptoms in patients with Alc…
Phase: PHASE2 • Sponsor: Beckley Psytech Limited • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a clinic-and-social-media campaign boost HIV prevention among black women?
Prevention CompletedThe study objectives are to: * Evaluate implementation outcomes from piloting the Start the Conversation Initiative * Assess initial indicators of clinical effectiveness among patients engaged in the Start the Conversation Initiative These outcomes will be assessed qualitativel…
Phase: NA • Sponsor: Duke University • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
New drug targets hidden tumor weakness in Hard-to-Treat cancers
Disease control Recruiting nowA modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokinetics of intravenous infusion of CP-506, a tumor agnostic Hypoxia Activated Prodrug in patients with HRD/FAD solid tumours or tumor types wit…
Phase: PHASE1, PHASE2 • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New combo aims to boost immunotherapy in elderly melanoma patients
Disease control Recruiting nowPrimary Objective: To evaluate the effectiveness of Thymosin Alpha-1 combined with PD-1 monoclonal antibody in elderly patients with advanced melanoma . Secondary Objective: To evaluate the safety and tolerability of adenpeptide-α1 combined with PD-1 antibody in elderly patien…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug targets Hard-to-Treat cancers by homing in on a specific protein
Disease control Recruiting nowThis is a Phase Ia/Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SG1906 in Patients with CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Solid Tumors.
Phase: PHASE1 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Brain training from home: could a smartphone app sharpen thinking in early psychosis?
Disease control OngoingThe purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. We will recr…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for rare skin cancer: targeted antibody tested in china
Disease control OngoingThe purpose of the study is to evaluate the efficacy and safety of mogamulizumab (KW-0761) in chinese subjects with mycosis fungoides or sézary syndrome previously treated with systemic therapy
Phase: PHASE4 • Sponsor: Kyowa Kirin China Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:41 UTC
-
New blood test could sniff out lung cancer early
Diagnosis CompletedCONQUER cancer study: To collect blood samples from cancer and non-cancer participants for development and validation of the 'OncoSweep Cancer Spotlight and Spectrum Product Line'
Sponsor: Pharus Taiwan, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 18:08 UTC
-
New drug shows promise for controlling rare kidney disorders
Disease control OngoingThis study is designed as a long-term extension to Study APL2-C3G-310, and is being conducted to establish the long-term safety and efficacy of pegcetacoplan in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN).
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Experimental drug shows promise for rare HIV-Linked cancer
Disease control OngoingThis is a phase 1b, open label, single arm study evaluating the safety and tolerability of the drug dostarlimab in combination antiretroviral therapy (cART) refractory HIV-associated Kaposi Sarcoma (KS), a rare type of cancer usually seen in people with the HIV infection. Dostar…
Phase: PHASE1 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can tiny screws make aneurysm repair safer for wide necks?
Disease control Recruiting nowThe HERCULES trial is a Randomized controlled clinical trial designed to prospectively compare endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) clinical outcomes in treatment of infrarenal abdominal aortic aneurysm (AAA) in subjects having wide pr…
Phase: NA • Sponsor: Rijnstate Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New Antibody-Drug conjugate targets advanced solid tumors in early trial
Disease control OngoingPhase I/II, dose escalation and dose expansion study to evaluate the efficacy and safety of MHB036C in advanced malignant tumors.
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New chemo combo shows promise for head and neck cancer before surgery
Disease control Completed\- Objective: Primary objective: To evaluate the major pathologic response (mPR) of locally advanced head and neck cancer after paclitaxel and carboplatin-induction chemotherapy followed by surgery. Secondary objective: To evaluate the efficacy and safety of induction chemothera…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Lupus drug anifrolumab put to the test in everyday patients
Disease control Recruiting nowBACKGROUND AND RATIONALE. The role of type I interferons (IFN) in innate and adaptive immunity has been extensively studied, establishing a key role for type I IFNs in immune homeostasis. With growing evidence that type I IFNs play an important role in autoimmune diseases, inhibi…
Sponsor: University of Pisa • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can we predict dangerous blood clots in lymphoma patients? a major study aims to find out
Knowledge-focused CompletedComparative Evaluation of Thrombotic Risk Models in DLBCL patients Objective: To assess the impact of thrombotic risk factors and compare the performance of existing predictive models (Khorana, Throly, Model IX) in Diffuse Large B-cell Lymphoma (DLBCL) Primary Endpoints: Measu…
Sponsor: Fondazione IRCCS San Gerardo dei Tintori • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New imaging agent could reveal which cancers respond to immunotherapy
Diagnosis Recruiting nowThis phase I/II clinical trial evaluates if using a radiotracer targeting granzyme B, 64-copper granzyme targeting restricted interaction peptide specific to family member B (64 Cu-GRIP B) with positron emission tomography (PET) imaging can be safe and useful for detecting granzy…
Phase: PHASE1, PHASE2 • Sponsor: Rahul Aggarwal • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Can a diabetes pill fix antipsychotic weight gain?
Disease control Recruiting nowOlanzapine is a thieno-benzodiazepine derivate that is effective managing the symptoms of schizophrenia and reducing the psychopathological symptoms of psychosis. It is also effective in controlling the acute manic episodes associated with bipolar disorder, and have provided some…
Phase: PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for tough thyroid cancers? cabozantinib trial shows promise
Disease control CompletedCABOTHYROID is a prospective, exploratory, biomarker-focused, phase II, single-arm, non-randomized, non-blinded, investigator-initiated study of cabozantinib in patients with previously treated advanced radioactive-iodine refractory
Phase: PHASE2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC